Specifically, 30.81% of participants receiving semaglutide experienced GI issues, while only 12.7% in the control group did
Your provider can assess whether alternative pain management strategies would be more appropriate, evaluate for underlying conditions requiring treatment, and review your complete medication regimen for potential interactions or cumulative risks
If you arent achieving your desired results with semaglutide, or if you have type 2 diabetes with severe insulin resistance, she often suggests switching to tirzepatide
Many studies show greater weight loss outcomes, but the best medication depends on your biology and goals
Gradual tapering produces better outcomes than abrupt discontinuation
For people with diabetes, insulin resistance, or medications that affect blood sugar, this is worth taking seriously